Example: Heart Attack

Clinical Trials on Congenital Adrenal Hyperplasia

Total 59 results

  • NCT00250159
    Enrolling by invitation
    Natural History Study of Patients With Excess Androgen
    Conditions: Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP)
  • NCT00001521
    Active, not recruiting
    Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia (CAH)
  • NCT04457336
    Recruiting
    A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH
    Conditions: Congenital Adrenal Hyperplasia
  • NCT04544410
    Recruiting
    A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
    Conditions: Congenital Adrenal Hyperplasia
  • NCT04903587
    Not yet recruiting
    Gonadal Changes In Congenital Adrenal Hyperplasia Patients
    Conditions: Congenital Adrenal Hyperplasia
  • NCT02716818
    Completed
    Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia
  • NCT04890444
    Not yet recruiting
    China Adrenal Disease Registry
    Conditions: Cushing Syndrome, Aldosteronism, Hypoadrenalism, Congenital Adrenal Hyperplasia, Adrenal Adenoma, Adrenal Incidentaloma, Adrenal Carcinoma, Pheochromocytoma
  • NCT04783181
    Not yet recruiting
    A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
    Conditions: Congenital Adrenal Hyperplasia
  • NCT04490915
    Recruiting
    Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia
  • NCT03062280
    Active, not recruiting
    A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH
    Conditions: Congenital Adrenal Hyperplasia
  • NCT04806451
    Recruiting
    Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
    Conditions: Congenital Adrenal Hyperplasia
  • NCT02804178
    Completed
    A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia
  • NCT03669549
    Terminated
    Nevanimibe HCl for the Treatment of Classic CAH
    Conditions: Congenital Adrenal Hyperplasia
  • NCT02574910
    Active, not recruiting
    Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
    Conditions: Congenital Adrenal Hyperplasia
  • NCT04045145
    Recruiting
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia
    Conditions: CAH - Congenital Adrenal Hyperplasia
  • NCT03548246
    Not yet recruiting
    Androgen Reduction in Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia
  • NCT03550261
    Recruiting
    Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia (CAH)
  • NCT03718234
    Recruiting
    Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia, Hyperplasia, Adrenal Hyperplasia, Congenital Disorders, Adrenocortical Hyperfunction, Disorders of Sex Development, Urogenital Abnormalities, Genetic Diseases, Inborn, Steroid Metabolic Diseases, Inborn, Adrenal Gland Disease, Hydrocortisone
  • NCT04536662
    Not yet recruiting
    Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency
    Conditions: Congenital Adrenal Hyperplasia
  • NCT03162159
    Completed
    Adult Height Prediction in Congenital Adrenal Hyperplasia
    Conditions: Congenital Adrenal Hyperplasia
  • NCT03525886
    Completed
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
    Conditions: CAH - Congenital Adrenal Hyperplasia
  • NCT02934399
    Active, not recruiting
    Dynamic Hormone Diagnostics in Endocrine Disease
    Conditions: Adrenal Insufficiency, Congenital Adrenal Hyperplasia, Cushing Syndrome, Growth Hormone Deficiency, Acromegaly, Primary Hyperaldosteronism
  • NCT04463316
    Recruiting
    GROWing Up With Rare GENEtic Syndromes
    Conditions: Prader-Willi Syndrome, PWS-like Syndrome, Silver Russel Syndrome, Congenital Hypopituitarism, Klinefelter (XXY-)Syndrome, Congenital Adrenal Hyperplasia, XXXXY Syndrome, XXYY Syndrome, XXXX Syndrome (Tetra-X Syndrome), Disorders of Sex Development, Turner Syndrome, 46, XY DSD, Tuberous Sclerosis, Neurofibromatosis, Albright Hereditaire Osteodystrofie, Cornelia de Lange Syndrome, Saethre-Chotzen Syndrome, 17p- Deletiesyndrome, VCF Syndrome, POLR3A Mutatie, Ohdo Syndrome, Jacobsen Syndrome / 11 q Syndrome, Myrhe Syndrome, CHARGE Syndrome, 1q25-32 Deletie, Bardet Biedl Syndrome, Rett Syndrome, 22q11 Deletion Syndrome, Allan-Herndon-Dudley Syndrome, Kallmann Syndrome, Rare Bone Disorders, Noonan Syndrome, Williams-Beuren Syndrome
  • NCT04252001
    Not yet recruiting
    Growing up With the Young Endocrine Support System (YESS!)
    Conditions: Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism, Growth Hormone Deficiency, Combined Pituitary Hormone Deficiency, Turner Syndrome, Klinefelter Syndrome, Addison's Disease, Androgen Insensitivity Syndrome, Thyroid Dysgenesis
  • NCT04293133
    Not yet recruiting
    Final Height in Patients With CAH
    Conditions: Congenital Adrenal Hyperplasia
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations